CNS Neuroscience & Therapeutics
Journal Title
- CNS Neuroscience & Therapeutics
ISSN
- E 1755-5949 | P 1755-5930
Publisher
- Wiley-Blackwell
Listed on(Coverage)
| JCR | 2008-2023 |
|---|---|
| SJR | 2009-2020;2022-2023 |
| CiteScore | 2011-2023 |
| SCIE | 2010-2024 |
| CC | 2016-2024 |
| SCOPUS | 2017-2024 |
| MEDLINE | 2016-2024 |
| DOAJ | 2019-2024 |
| EMBASE | 2016-2024 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | neuroscience, neurology, central nervous system, pharmacology, degenerative diseases, pharmacokinetics |
| Review Process | Anonymous peer review |
| Journal info. pages | |
| Licences | CC BY |
| Copyrights | Yes |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Therapeutics. Pharmacology | Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry |
Active
- Active
based on the information
- SCOPUS:2024-10
Country
- USA
Aime & Scopes
- CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.